Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Indian Equities: Mahindra Financial, Orient Green, Ranbaxy

Don't Miss Out —
Follow us on:

Dec. 22 (Bloomberg) -- India’s Bombay Stock Exchange’s Sensitive Index, or Sensex, fell 44.52, or 0.2 percent, to 20,015.80 at the 3:30 p.m. close in Mumbai. Shares of the following companies had unusual moves and stock symbols are in parentheses.

Indiabulls Financial Services Ltd. (IBULL IN) advanced 2.2 percent to 173.65 rupees, its highest in more than two weeks. About 1 percent of its equity changed hands in two block deals in Mumbai, according to Bloomberg data. Buyers and sellers weren’t immediately known.

J. Kumar Infraprojects Ltd. (JKIL IN), a construction company, climbed 5.4 percent to 180.95 rupees after saying it won orders worth 369 million rupees ($8.19 million).

Mahindra & Mahindra Financial Services Ltd. (MMFS IN), a unit of India’s biggest maker of sport-utility vehicles, lost 3.1 percent to 707.5 rupees, its lowest in two months. About 2.3 percent of its equity changed hands in four block deals in Mumbai, according to Bloomberg data. Buyers and sellers weren’t immediately known.

Orient Green Power Ltd. (OGPL IN), a developer of renewable-energy projects, surged 15 percent to 29.3 rupees, the most since it began trading. About 1.7 percent of its equity changed hands in five block deals in Mumbai, according to Bloomberg data. Buyers and sellers weren’t immediately known.

Ranbaxy Laboratories Ltd. (RBXY IN) increased 2.1 percent to 570.55 rupees. The drugmaker’s Romanian unit, Terapia SA, plans to invest $50 million in a new plant, Ziarul Financiar reported. Krishnan Ramalingam and Raghu Kochar, spokesmen at Ranbaxy, didn’t return calls to their office and cell phone seeking comment on the report.

To contact the reporter on this story: Hemal Savai in Mumbai at at hsavai@bloomberg.net

To contact the editor responsible for this story: Stephen Foxwell at at sfoxwell@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.